Advertisement
"We are very appreciative of everyone involved in the GCP program,"commented Linkwell Chairman and CEO, Mr. Xuelian Bian. "The process andproducts will help us to reach the next two levels in our businessdevelopment." The program's objectives were to bring new strategic thinkingand ideas to Linkwell; discuss growth plan details, action steps, and sharecritical factors for driving growth; discuss the business plan; engageindustry experts on relevant topics for insights; and provide writtenmaterials to the Company, including a business plan, to accomplish theseobjectives.
Advertisement
During the GCP program which lasted six months, participants evaluated 5disinfectant markets for size, growth trends, risks and barriers to entry.Then they developed a deep analysis of the market environment for the medicalsector, with special focus on customers; competitors; distribution networkanalysis; and growth strategy initiatives. The program concluded with thewriting and presentation of a customized business plan containing financialprojections; a funding plan; an implementation plan for growth initiatives,including sales effectiveness, pricing, marketing, innovations, acquisitionsand pharmacy market sizing.
The GCP report stated, "Already exceeding RMB 6.5B (US$ 928M), China'smedical disinfectant market is expected to grow steadily at 15% over the nextfive years. Beyond medical disinfectants, opportunities abound in China'snascent home-use disinfectants market (approximately RMB 14B/US$ 2B andgrowing at 13% per year) and the market for commercial-use disinfectants(approximately RMB 4B/US$ 571M and growing at 15% per year)". GCP recommendedLinkwell Corporation focus on medical disinfectants at the present time, thengo into home-use disinfectants market in the near future.
"The preparation and research was detailed, academically rigorous,practical," commented Linkwell COO, Mr. Arthur Huang. "The planning ispragmatic, creative, innovative, flexible; I believe we can integrate theirfour stage business strategy with the one we had created."
The plan and other products provide Linkwell with deep market analysis,including opportunities and risks and a thorough corporate analysis ofLinkwell and the competition's strengths and weaknesses. In the colloquium,Linkwell's management team dialogued with many industry experts, includingsales, marketing and law experts. Many of these experts serve on the GCPboard of directors with many years of experience in their fields, and sharedtheir real-life advice and experience to Linkwell.
Mr. Bian concluded, "We highly value the Wharton GCP four stage businessstrategy and support products. Everyone has lived up to Wharton and Fudan'sesteemed reputation and their work was truly impressive and greatlyappreciated. In fact, we believe that this information is so powerful that weplan to use it for years to come to help us grow into a large and successfulcompany."
About Linkwell Corporation
Linkwell develops, manufactures and distributes disinfectant healthcareproducts in China through its subsidiary LiKang Disinfectant. Linkwell'sdisinfectant healthcare products are a nationally recognized domestic Chinesebrand in this market segment. Linkwell products include disinfectants inliquid, tablet, powder and aerosol form. Through LiKang, Linkwell has anational marketing and sales presence throughout
